'de novo' NAD biosynthetic process

pathway activity — cross-omics
GO:0034627Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the 'de novo' NAD biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the HNSC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are SLA2, PTPN22, and CD3G, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile.

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
HNSCSLA2 →+0.757+0.235<.001<.00137
HNSCPTPN22 →+0.747+0.240<.001<.00135
HNSCCD3G →+0.839+0.206<.001<.00135
HNSCCCDC141 →+0.473+0.137.002.00335
HNSCCD247 →+0.753+0.210.001<.00135
HNSCCD3E →+0.869+0.166<.001.00835
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

Exploration